| 摘要 |
Treatment of central nervous system disorders with (1R,4S)-trans 4-(3,4- dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine and with (1S,4R )- trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro -N- methyl-1-napthalenamine is also disclosed.
|
